Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
07/2003
07/10/2003WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
07/10/2003US20030130506 4-phenoxy or 4-(pyrid-4-yloxy)- benzensulfonic acid derivatives; antitumor and antiarthritic agents
07/10/2003US20030130285 Controlling cell differentiation, cell proliferation
07/10/2003US20030130255 Pyridoquinoxaline antivirals
07/10/2003US20030129552 Color photothermography
07/09/2003EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same
07/09/2003EP1325671A1 Organometallic compounds and emission-shifting organic electrophosphorescence
07/09/2003EP0966490B1 Catalyst compositions for the polymerization of olefins
07/09/2003CN1429229A Hydroxylamine esters as polymerization initiators
07/09/2003CN1429198A Novel phenyl-proparylether derivatives
07/03/2003WO2003053972A1 Pyridoquinoxaline antivirals
07/03/2003WO2003053971A1 Pyridoquinoxaline antivirals
07/03/2003WO2003053942A1 Aryloxyphenyl and arylsulfanylphenyl derivatives
07/03/2003WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives
07/03/2003WO2003053443A1 Substituted diketopiperazines as oxytocin antagonists
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003US20030125494 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
07/03/2003US20030125334 5-HT receptor ligands and uses thereof
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003CA2473862A1 Pyridoquinoxaline antivirals
07/03/2003CA2471355A1 Substituted diketopiperazines as oxytocin antagonists
07/03/2003CA2471089A1 Pyridoquinoxaline antivirals
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2467118A1 Aryloxyphenyl and arylsulfanylphenyl derivatives
07/02/2003EP1322654A1 Platinum complexes as antitumor agents
07/02/2003EP1322643A1 Piperazin-2-one amides as inhibitors of factor xa
07/02/2003EP1140861B1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
07/02/2003EP0944582B1 Ketobenzamides as calpain inhibitors
07/02/2003CN1427827A 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/01/2003US6586466 Carbohydrazide-protease inhibitors
07/01/2003US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
07/01/2003US6586418 Heteroaryl-phenyl substituted compounds that are inhibitors of trypsin-like serine protease enzymes; anticoagulant for treatment and prevention of thromboembolic disorders
06/2003
06/26/2003WO2003051851A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
06/26/2003WO2003051850A1 Pyrazine compounds and pharmaceutical compositions containing them
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051119A1 New herbicidal compounds and method
06/26/2003US20030120066 Synthetic peptides
06/26/2003US20030119864 Farnesyl transferase inhibitors
06/26/2003US20030119851 In the treatment or prevention of psychotic disorders such as schizophrenia psychotic depression, mania and other central nervous system diseases
06/26/2003US20030119844 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/26/2003US20030119721 Electrophilic ketones for the treatment of herpesvirus infections
06/26/2003CA2469786A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1001942B1 Polyhydroxybutylpyrazines, their preparation and medicines containing them
06/25/2003CN1426409A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003US20030114679 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/19/2003US20030114423 Arylamines as inhibitors of chemokine binding to US28
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003CN1424313A Chuanxiong alkoxide derivative and its preparation and medicinal composition containing it and use thereof
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/12/2003WO2003048127A1 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003047569A1 Compositions and methods for inhibiting prenyltransferases
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109556 Melanocortin receptor ligands
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them
06/10/2003US6576791 Local anesthetic compounds and uses
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2120020C Air treatment plant for foodstuff comprising a trough with an adjustable width
06/10/2003CA2083505C New use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disorders
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003045924A1 Substituted aryl 1,4-pyrazine derivatives
06/05/2003WO2003045923A1 Preventives or remedies for alzheimer’s disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045393A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105122 Compounds for enhancing chemotherapy
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments
06/05/2003CA2467966A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003CA2467870A1 Substituted aryl 1,4-pyrazine derivatives
06/04/2003EP1282609A4 Piperazinedione compounds
06/04/2003EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
06/04/2003CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
06/04/2003CN1422251A Novel alpha-sulfin-and alpha-sulfonamino acid amide derivatives
1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 187